Milestone Pharmaceuticals (MIST) Treasury Shares (2018 - 2026)
Milestone Pharmaceuticals' (MIST) quarterly Treasury Shares came in at $2.3 million in Q1 2026, up 133.07% YoY from $988850.0 in Q1 2025, and up 142.42% on a QoQ basis from $950700.0 in Q4 2025.
Milestone Pharmaceuticals (MIST) Treasury Shares (2018 - 2026) Analysis & Trends
Milestone Pharmaceuticals (MIST) has 5 years of Treasury Shares data on file, last reported at $2.3 million in Q1 2026.
- Quarterly Treasury Shares rose 133.07% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (up 133.07% YoY) and the FY2025 annual result came in at $950700.0, up 2.89% from the prior year.
- Treasury Shares advanced to $2.3 million in Q1 2026, from $950700.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $2.3 million in Q1 2026 to a low of $924000.0 in Q2 2024.
- A 3-year average of $1.2 million and a median of $937350.0 in 2024 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2025 — Treasury Shares climbed 2.89% — and 2026, when it surged 133.07%.
- Tracing MIST's Treasury Shares over 3 years: stood at $924000.0 in 2024, then climbed by 2.89% to $950700.0 in 2025, then soared by 142.42% to $2.3 million in 2026.
- The last three Treasury Shares figures came in at $2.3 million (Q1 2026), $950700.0 (Q4 2025), and $988850.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.91 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.87 Bn | 59.68 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.18 Bn | 53.04 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.96 Bn | 36.87 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.23 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.79 Bn | 9.40 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.37 Bn | 26.53 Bn | - | 2.72 Mn |
| 10 | Milestone Pharmaceuticals | 43.32 Mn | -128.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.30 Mn |
| Jun 30, 2026 | 2.30 Mn |
| Mar 31, 2026 | 2.30 Mn |
| Mar 31, 2026 | 2.30 Mn |
| Dec 31, 2025 | 950,700.00 |
| Dec 31, 2025 | 950,700.00 |
| Mar 31, 2025 | 988,850.00 |
| Mar 31, 2025 | 988,850.00 |
| Dec 31, 2024 | 924,000.00 |
| Dec 31, 2024 | 924,000.00 |
| Sep 30, 2024 | 924,000.00 |
| Sep 30, 2024 | 924,000.00 |
| Jun 30, 2024 | 924,000.00 |
| Jun 30, 2024 | 924,000.00 |
| Jun 30, 2019 | -2.83 Mn |
| Jun 30, 2019 | -2.83 Mn |
| Mar 31, 2019 | 2.44 Mn |
| Mar 31, 2019 | 2.44 Mn |
| Dec 31, 2018 | 2.83 Mn |
| Dec 31, 2018 | 2.83 Mn |